Vol. 26 No. 2 (2022)
CASE REPORTS

Case report of a multidisciplinary approach to one-time treatment of a patient with critical aortic valve stenosis, lesion of the left main coronary artery and bleeding stomach cancer

PDF (Русский)
  • B.G. Alekyan,
  • D.V. Ruchkin,
  • N.G. Karapetyan,
  • N.L. Irodova,
  • N.N. Meleshenko,
  • L.G. Geletsyan,
  • A.Sh. Revishvili
B.G. Alekyan
A.V. Vishnevsky National Medical Research Center of Surgery, Moscow
D.V. Ruchkin
A.V. Vishnevsky National Medical Research Center of Surgery, Moscow
N.G. Karapetyan
A.V. Vishnevsky National Medical Research Center of Surgery, Moscow
Bio
N.L. Irodova
A.V. Vishnevsky National Medical Research Center of Surgery, Moscow
N.N. Meleshenko
A.V. Vishnevsky National Medical Research Center of Surgery, Moscow
L.G. Geletsyan
A.V. Vishnevsky National Medical Research Center of Surgery, Moscow
A.Sh. Revishvili
A.V. Vishnevsky National Medical Research Center of Surgery, Moscow
Коронарография после чрескожного коронарного вмешательства
DOI: https://doi.org/10.21688/1681-3472-2022-2-58-65

Published 2022-06-30

Keywords

  • aortic valve stenosis,
  • case report,
  • percutaneous coronary intervention,
  • stomach cancer,
  • transcatheter aortic valve implantation

How to Cite

Alekyan, B., Ruchkin, D., Karapetyan, N., Irodova, N., Meleshenko, N., Geletsyan, L., & Revishvili, A. (2022). Case report of a multidisciplinary approach to one-time treatment of a patient with critical aortic valve stenosis, lesion of the left main coronary artery and bleeding stomach cancer. Patologiya Krovoobrashcheniya I Kardiokhirurgiya, 26(2), 58–65. https://doi.org/10.21688/1681-3472-2022-2-58-65

Copyright (c) 2022 Alekyan B.G., Ruchkin D.V., Karapetyan N.G., Irodova N.L., Meleshenko N.N., Geletsyan L.G., Revishvili A.Sh.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Abstract

Aortic valve stenosis and bleeding gastric cancer are formidable diseases characterized by high mortality. For a long time, the gold standard for treating patients with aortic stenosis has been open-heart surgery — aortic valve replacement. However, the endovascular operation that appeared in 2002 — transcatheter aortic valve implantation (TAVI) has become the standard of care for patients with high surgical risk. Gastric cancer is one of the major severe oncological diseases in which surgery is the only way to cure. The combination of these two diseases significantly worsens the prognosis and is a difficult clinical task for choosing the optimal tactics for treating a patient. Given the lack of developed standards for the treatment of multimorbid patients, the treatment plan is determined by an interdisciplinary consultation. But with a combination of these diseases, there is no generally accepted approach in the known recommendations.

The purpose of this report is to present a clinical case of a patient with critical aortic stenosis, concomitant severe coronary artery disease, and bleeding stomach cancer, who underwent a successful one-stage operation — percutaneous coronary intervention, TAVI and open gastrectomy with Roux-loop reconstruction with one anesthetic aid by the decision of a multidisciplinary team. The patient was discharged in a satisfactory condition. In the late follow-up period, angina pectoris returned with restenosis of the stent in the anterior interventricular branch (LAD), which required repeated intervention in the form of LAD restenting with a good clinical result.

A hybrid approach in the treatment of patients with critical aortic valve stenosis in combination with coronary artery disease and bleeding gastric cancer can be accepted as one of the possible strategies, but further research is needed in this direction.

Received 15 October 2021. Revised 20 January 2022. Accepted 31 January 2022.

Informed consent: The patient’s informed consent to use the records for medical purposes is obtained.

Funding: The study did not have sponsorship.

Conflict of interest: Authors declare no conflict of interest.

Contribution of the authors
Literature review: N.L. Irodova, L.G. Geletsyan
Drafting the article: N.G. Karapetyan, N.N. Meleshenko
Critical revision of the article: B.G. Alekyan, A.Sh. Revishvili
Surgical treatment: B.G. Alekyan, D.V. Ruchkin, N.G. Karapetyan, N.N. Meleshenko
Final approval of the version to be published: B.G. Alekyan, D.V. Ruchkin, N.G. Karapetyan, N.L. Irodova, N.N. Meleshenko, L.G. Geletsyan, A.Sh. Revishvili

PDF (Русский)

References

  1. Cribier A., Eltchaninoff H., Bash A., Borenstein N., Tron C., Bauer F., Derumeaux G., Anselme F., Laborde F., Leon M.B. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation. 2002;106(24):3006-3008. PMID: 12473543. https://doi.org/10.1161/01.CIR.0000047200.36165.B8
  2. Cribier A., Savin T., Saoudi N., Rocha P., Berland J., Letac B. Percutaneous transluminal valvuloplasty of acquired aortic stenosis in elderly patients: an alternative to valve replacement? Lancet. 1986;1(8472):63-67. PMID: 2867315. https://doi.org/10.1016/S0140-6736(86)90716-6
  3. Алекян Б.Г., Григорьян А.М., Стаферов А.В., Карапетян Н.Г. Рентгенэндоваскулярная диагностика и лечение заболеваний сердца и сосудов в Российской Федерации – 2019 год. Эндоваскулярная хирургия. 2020;7(2, спец. вып.):S5-S230. https://doi.org/10.24183/2409-4080-2020-7-2S-S5-S230 Alekyan B.G., Grigoryan A.M., Staferov A.V., Karapetyan N.G. Endovascular diagnostics and treatment of diseases of the heart and blood vessels in the Russian Federation – 2019. Endovaskulyarnaya Khirurgiya = Russian Journal of Endovascular Surgery. 2020;7(2, Special Iss.):S5-S230. (In Russ.) https://doi.org/10.24183/2409-4080-2020-7-2S-S5-S230
  4. Алекян Б.Г., Григорьян А.М., Стаферов А.В., Карапетян Н.Г. Рентгенэндоваскулярная диагностика и лечение заболеваний сердца и сосудов в Российской Федерации – 2017 год. Эндоваскулярная хирургия. 2018;5(2, спец. вып.):93-240. https://doi.org/10.24183/2409-4080-2018-5-2-93-240 Alekyan B.G., Grigoryan A.M., Staferov A.V., Karapetyan N.G. Endovascular diagnostics and treatment in the Russian Federation (2017). Endovaskulyarnaya Khirurgiya = Russian Journal of Endovascular Surgery. 2018;5(2, Special Iss.):93-240. (In Russ.) https://doi.org/10.24183/2409-4080-2018-5-2-93-240
  5. D'Ascenzo F., Verardi R., Visconti M., Conrotto F., Scacciatella P., Dziewierz A., Stefanini G.G., Paradis J.-M., Omedè P., Kodali S., D'Amico M., Rinaldi M., Salizzoni S. Independent impact of extent of coronary artery disease and percutaneous revascularization on 30-day and 1-year mortality after TAVI: a meta-analysis of adjusted observational results. EuroIntervention. 2018;14(11):e1169-e1177. PMID: 30082258. https://doi.org/10.4244/eij-d-18-00098
  6. Cao D., Chiarito M., Pagnotta P., Reimers B., Stefanini G.G. Coronary revascularisation in transcatheter aortic valve implantation candidates: Why, who, when? Interv Cardiol. 2018;13(2):69-76. PMID: 29928311; PMCID: PMC5980648. https://doi.org/10.15420/icr.2018:2:2
  7. Sakai T., Yahagi K., Miura S., Hoshino T., Yokota T., Tanabe K., Ikeda S. Transcatheter aortic valve implantation for patients with lung cancer and aortic valve stenosis. J Thorac Dis. 2018;10(5):E387-E390. PMID: 29998000; PMCID: PMC6006067. https://doi.org/10.21037/jtd.2018.04.83
  8. Nagata H., Kanzaki R., Kanou T., Ose N., Funaki S., Shintani Y., Minami M., Mizote I., Sakata Y., Maeda K., Kuratani T., Sawa Y., Okumura M. Two cases of lobectomy for lung cancer after transcatheter aortic valve implantation. Surg Case Rep. 2018;4(1):139. PMID: 30511270; PMCID: PMC6277400. https://doi.org/10.1186/s40792-018-0548-7
  9. Iung B., Delgado V., Rosenhek R., Price S., Prendergast B., Wendler O., De Bonis M., Tribouilloy C., Evangelista A., Bogachev-Prokophiev A., Apor A., Ince H., Laroche C., Popescu B.A., Piérard L., Haude M., Hindricks G., Ruschitzka F., Windecker S., Bax J.J., Maggioni A., Vahanian A., EORP VHD II Investigators. Contemporary presentation and management of valvular heart disease: The EURObservational Research Programme Valvular Heart Disease II Survey. Circulation. 2019;140(14):1156-1169. PMID: 31510787. https://doi.org/10.1161/CIRCULATIONAHA.119.041080
  10. Iung B., Baron G., Butchart E.G., Delahaye F., Gohlke-Bärwolf C., Levang O.W., Tornos P., Vanoverschelde J.-L., Vermeer F., Boersma E., Ravaud P., Vahanian A. A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on Valvular Heart Disease. Eur Heart J. 2003;24(13):1231-1243. PMID: 12831818. https://doi.org/10.1016/s0195-668x(03)00201-x
  11. Faggiano P., Frattini S., Zilioli V., Rossi A., Nistri S., Dini F.L., Lorusso R., Tomasi C., Cas L.D. Prevalence of comorbidities and associated cardiac diseases in patients with valve aortic stenosis. Potential implications for the decision-making process. Int J Cardiol. 2012;159(2):94-99. PMID: 21376407. https://doi.org/10.1016/j.ijcard.2011.02.026